EurekaMag
+ Most Popular
Cunninghamia lanceolata plantations in China
Mammalian lairs in paleo ecological studies and palynology
Studies on technological possibilities in utilization of anhydrous milk fat for production of recombined butter-like products
Should right-sided fibroelastomas be operated upon?
Large esophageal lipoma
Apoptosis in the mammalian thymus during normal histogenesis and under various in vitro and in vivo experimental conditions
Poissons characoides nouveaux ou non signales de l'Ilha do Bananal, Bresil
Desensitizing efficacy of Colgate Sensitive Maximum Strength and Fresh Mint Sensodyne dentifrices
Administration of fluid by subcutaneous infusion: revival of a forgotten method
Tundra mosquito control - an impossible dream?
Schizophrenia for primary care providers: how to contribute to the care of a vulnerable patient population
Geochemical pattern analysis; method of describing the Southeastern limestone regional aquifer system
Incidence of low birth weights in a hospital of Mexico City
Tabanidae
Graded management intensity of grassland systems for enhancing floristic diversity
Microbiology and biochemistry of cheese and fermented milk
The ember tetra: a new pygmy characid tetra from the Rio das Mortes, Brazil, Hyphessobrycon amandae sp. n. (Pisces, Characoidei)
Risk factors of contrast-induced nephropathy in patients after coronary artery intervention
Renovation of onsite domestic wastewater in a poorly drained soil
Observations of the propagation velocity and formation mechanism of burst fractures caused by gunshot
Systolic blood pressure in a population of infants in the first year of life: the Brompton study
Haematological studies in rats fed with metanil yellow
Studies on pasteurellosis. I. A new species of Pasteurella encountered in chronic fowl cholera
Dormancy breaking and germination of Acacia salicina Lindl. seeds
therapy of lupus nephritis. a two-year prospective study

The Evaluation of Valsartan Biopharmaceutics Properties


The Evaluation of Valsartan Biopharmaceutics Properties



Current Drug Research Reviews 12(1): 52-62



ISSN/ISBN: 2589-9775

PMID: 31820707

Solubility, intestinal permeability and dissolution are the main factors that govern the rate and extent of drugs absorption and are directly related to bioavailability. Biopharmaceutics Classification System (BCS) is an important tool which uses in vitro results for comparison with bioavailability in vivo (biowaiver). Valsartan is widely used in the treatment of hypertension and shows different BCS classification in the literature (BCS class II or III). This work proposes the study of valsartan biopharmaceutics properties and its BCS classification. High Performance Liquid Chromatography (HPLC) method was developed and validated to quantify the drug in buffers pH 1.2, 4.5 and 6.8 respectively. Valsartan solubility was determined in these three different media using shake flask method and intrinsic dissolution rate. Evaluation of dissolution profile from coated tablets was conducted. The low solubility (pH 1.2 and 4.5) and high solubility (pH 6.8) were observed for both solubility methods. Permeability data reported from the literature showed that valsartan is a low permeability drug. Valsartan presented the rapid release profile only in pH 6.8. We defined that valsartan is a class IV drug, in disagreement with what has been published so far. It is important to emphasize that the conditions considered here are indicated to define the biopharmaceutics classification by regulatory agencies.

Accession: 069600007

Download citation: RISBibTeXText

Related references

The Evaluation of Valsartan Biopharmaceutics Properties. Current Drug Research Reviews 12(1): 52-62, 2020

Evaluation of the dose response with valsartan and valsartan/hydrochlorothiazide in patients with essential hypertension. Journal of Clinical Hypertension 9(2): 103-112, 2007

Interplay of biopharmaceutics, biopharmaceutics drug disposition and salivary excretion classification systems. Saudi Pharmaceutical Journal: Spj: the Official Publication of the Saudi Pharmaceutical Society 22(1): 79-81, 2014

Applying the biopharmaceutics classification system to veterinary pharmaceutical products. Part I: biopharmaceutics and formulation considerations. Advanced Drug Delivery Reviews 54(6): 805-824, 2002

Biopharmaceutics and pharmacokinetics A historical approach III Biopharmaceutics Bioavailability testing. Ciencia Pharmaceutica 3(1): 41-54, 1993

Biopharmaceutics and pharmacokinetics A historical approach III Biopharmaceutics Modulation of bioavailability. Ciencia Pharmaceutica 3(2): 97-116, 1993

Evaluation of Cardiac Function by Transthoracic Echocardiography in Subjects with ST-Segment Elevation Myocardial Infarction Following Primary Percutaneous Coronary Intervention according to Valsartan Dose: The Valsartan One Center Trial. Journal of Cardiovascular Ultrasound 18(3): 77-83, 2010

Echocardiographic evaluation of the effects of sacubitril-valsartan on vascular properties in heart failure patients. International Journal of Cardiovascular Imaging 36(2): 271-278, 2020

Evaluation of arterial stiffness in morning hypertension under high-dose valsartan compared to valsartan plus low-dose diuretic. Hypertension Research: Official Journal of the Japanese Society of Hypertension 32(12): 1086-1090, 2009

The efficacy and safety of valsartan and a combination of valsartan and hydrochlorothiazide in the treatment of patients with mild to moderate arterial hypertension: a subgroup analysis of the effect of valsartan and its combination with…. Kardiologia Polska 76(2): 328-337, 2018

A multicenter, randomized, and double-blind phase IV clinical trial to compare the efficacy and safety of fixed-dose combinations of amlodipine orotate/valsartan 5/160 mg versus valsartan/hydrochlorothiazide 160/12.5 mg in patients with essential hypertension uncontrolled by valsartan 160 mg monotherapy. Medicine 97(37): E12329, 2018

Multinational economic evaluation of valsartan in patients with chronic heart failure: results from the Valsartan Heart Failure Trial (Val-HeFT). American Heart Journal 148(1): 122-128, 2004

A validated Rp-Hplc method for the determination of rosuvastatin in presence of sacubitril/valsartan in rat plasma: Application to in vivo evaluation of Oatp-mediated drug interaction potential between rosuvastatin and sacubitril/valsartan. Microchemical Journal 143: 31-38, 2018

Drug evaluation by biopharmaceutics classification system. Drug Metabolism Reviews 35(Suppl 2): 216, 2003

Biopharmaceutics classification evaluation for paris saponin VIi. Chinese Journal of Natural Medicines 18(9): 714-720, 2020